Search results for: treatment
Giving Toesday
Giving Tuesday is a global day of generosity that inspires people everywhere to give back...
Novartis 1A – Patient Lived Experience Project
About this study Share your experiences with Charcot-Marie-Tooth disease type 1A (CMT1A) in an online...
Every Story Moves Us Closer
Every Story Moves Us Closer Each step forward in CMT research is powered by stories...
Team Julia 2025
Julia, and thousands of young adults and children with CMT, share a dream. They want...
Charcot-Marie-Tooth Association Appoints Catie Coman as Chief Marketing Officer
Coman brings more than 15 years of experience in patient advocacy and has worked with non-profit organizations serving people living with psoriatic disease, inflammatory arthritis, atopic dermatitis, type 1 diabetes, and other chronic diseases.
CMTA Welcomes Catie Coman as Chief Marketing Officer
CMTA welcomes Catie Coman as Chief Marketing Officer, bringing more than 15 years of experience in patient advocacy to lead marketing and communications strategy.
ENCell Announces Phase 1b/2a Stem Cell Trial for CMT1A
Could stem cells change the path of CMT research? ENCell announces stem cell clinical trial for CMT1A.
Orthogonal Neuroscience
Orthogonal Neuroscience Inc. is a developer of novel therapeutics designed to treat neurodegenerative diseases including...
Novartis
Novartis is a multinational Swiss pharmaceutical company, focusing on developing and marketing innovative medicines, including prescription...
Elpida Therapeutics
Elpida’s mission aims to address the current and significant unmet medical needs of patients with...